Skip to main content
. 2020 Dec 22;35(1):451–455. doi: 10.1111/jvim.16018

TABLE 3.

Summary of age and tumor characteristics of the 7 dogs in which an mast cell tumor recurred at the treatment site during the 12 months after administration of single intratumoral injection of tigilanol tiglate

Time of recurrence Patient age (years) Tumor location Tumor cytological grade Tumor volume at treatment (cm3)
Day 84 11.2 Trunk High 2.6
Day 84 11.6 Upper limb Low 1
Day 84 7.0 Head Low 1.8
Day 84 13.1 Lower limb Low 9.1
Day 84 7.7 Head Low 0.6
6 mo 7.9 Trunk High suspected 0.3
6 mo 3.5 Upper limb Low 1